Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Brain Cancer treatment details. Chemotherapy. Radiation. University of Tubingen Medical School, Tubingen, Germany



Survival: 11.0 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
Radiation
   
Drugs: Gemzar
Country: Germany
   
City/State/Province: Tubingen
   
Hospital: University of Tubingen Medical School
   
Journal: Link
   
Date: 1/2001

Description:
Patients: Twenty-one patients with newly diagnosed glioblastoma were enrolled in this Phase II study.

Treatment: The treatment consisted of preirradiation chemotherapy gemcitabine (gemzar), followed by standard radiotherapy.

Toxicity: In the first cycle, three patients had grade 1 myelotoxicity, 2 had grade 2 myelotoxicity, and 2 had grade 3 myelotoxicity. In the second cycle, 5 patients had grade 1 myelotoxicity and 1 patient had a grade 2 myelotoxicity. One patient developed fatal bacterial pneumonia.

Results: The median overall survival was 11 months.

Support: The study was supported by Lilly. Eli Lilly markets Gemzar.

Correspondence: Michael Weller, MD

E-mail to a Friend Email Physician More Information